Recombinant Anti-CD89 x Anti-EGFR Bispecific Antibody (Bibody) is a Fab-scFv format that uses heterodimeric Fab as a scaffold, and a scFv region linked to one of its heavy (Fd) or light (L) chain. The scFv of the anti-CD89 specificity is fused to the anti-CD89 heavy or light chain of the Fab. This BsAb can retarget macrophages to tumor cells. It is designed for the research of Head and neck cancer; Colorectal cancer (CRC); Glioblastoma multiforme (GBM); Squamous cancer; Non-small cell lung cancer (NSCLC); Solid tumors therapy.
Welcome! For price inquiries, we will get back to you as soon as possible.
INQUIRY